StockNews.com began coverage on shares of Vascular Biogenics (NASDAQ:VBLT – Get Rating) in a report published on Sunday. The firm issued a sell rating on the biopharmaceutical company’s stock. Vascular Biogenics Price Performance VBLT opened at $0.17 on Friday. The business has a fifty day simple moving average of $0.15 and a 200 day simple […]
StockNews.com began coverage on shares of Vascular Biogenics (NASDAQ:VBLT – Get Rating) in a research note issued to investors on Sunday. The firm issued a sell rating on the biopharmaceutical company’s stock. Vascular Biogenics Stock Performance NASDAQ:VBLT opened at $0.17 on Friday. The stock’s 50 day moving average price is $0.15 and its 200 day […]
StockNews.com started coverage on shares of Vascular Biogenics (NASDAQ:VBLT – Get Rating) in a research note published on Sunday. The firm issued a sell rating on the biopharmaceutical company’s stock. Vascular Biogenics Price Performance Shares of VBLT stock opened at $0.17 on Friday. The stock has a market cap of $11.86 million, a P/E ratio […]
Wall Street analysts expect Vascular Biogenics Ltd. (NASDAQ:VBLT – Get Rating) to post $160,000.00 in sales for the current fiscal quarter, Zacks Investment Research reports. Three analysts have provided estimates for Vascular Biogenics’ earnings. The highest sales estimate is $200,000.00 and the lowest is $100,000.00. Vascular Biogenics posted sales of $190,000.00 during the same quarter […]
Analysts expect Vascular Biogenics Ltd. (NASDAQ:VBLT – Get Rating) to announce ($0.13) earnings per share (EPS) for the current quarter, Zacks Investment Research reports. Three analysts have provided estimates for Vascular Biogenics’ earnings, with estimates ranging from ($0.14) to ($0.12). Vascular Biogenics posted earnings of ($0.12) per share in the same quarter last year, which […]